New Pre-Clinical Data on OSSURE LOEP published in Journal of Orthopedic Research

AGN1 Biomechanics in Cadaveric Femurs – (Publication)

Current pharmaceutical therapies can reduce hip fractures by up to 50%, but compliance to treatment is low and therapies take up to 18 months to reduce risk.  Thus, alternative or complementary approaches to reduce the risk of hip fracture are needed.  The AGN1 local osteo-enhancement procedure (LOEP) is one such alternative approach, as it is designed to locally replace bone lost due to osteoporosis and provide immediate biomechanical benefit.

This in vitro study evaluated the initial biomechanical impact of this treatment on human cadaveric femurs. We obtained 45 pairs of cadaveric femurs from women aged 77.8 ± 8.8 years. One femur of each pair was treated, while the contralateral femur served as an untreated control.  Treatment included debridement, irrigation/suction, and injection of a triphasic calcium-based implant (AGN1).  Mechanical testing of the femora was performed in a sideways fall configuration 24 hours after treatment.  Of the 45 pairs, 4 had normal, 16 osteopenic, and 25 osteoporotic BMD T-scores.  Altogether, treatment increased failure load on average by 20.5% (p<0.0001).  In the subset of osteoporotic femurs, treatment increased failure load by 26% and work to failure by 45% (p<0.01 for both). Treatment did not significantly affect stiffness in any group.

These findings provide evidence that local delivery of the triphasic calcium-based implant in the proximal femur is technically feasible and provides immediate biomechanical benefit. Our results provide strong rationale for additional studies investigating the utility of this approach for reducing the risk of hip fracture. This article is protected by copyright. All rights reserved


Archive

Category